VVP
CARM

Venture Visionary Partners’s Carisma Therapeutics CARM Stock Holding History

Venture Visionary Partners’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,500
Closed -$18.3K – 499
2022
Q4 		$18.3K Sell
1,500
-1,767
-54% -$18.6K ﹤0.01% 470
2022
Q3 		$27K Hold
3,267
– – ﹤0.01% 457
2022
Q2 		$53K Hold
3,267
– – ﹤0.01% 788
2022
Q1 		$39K Buy
3,267
+1,000
+44% +$14K ﹤0.01% 500
2021
Q4 		$36K Buy
2,267
+250
+12% +$5.03K ﹤0.01% 517
2021
Q3 		$32K Hold
2,017
– – ﹤0.01% 505
2021
Q2 		$186K Buy
+2,017
New +$129K 0.01% 480

Other funds holding CARM

TOTUOP
Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $297M AUM
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
Deuterium Capital Management Clearwater, Florida $86M AUM 87.31% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Venture Visionary Partners's CARM Position: Q1 2023 in Review

Venture Visionary Partners sold out of Carisma Therapeutics (CARM) in Q1 2023, closing a stake of 1,500 shares — an estimated $18.3K sold.

Venture Visionary Partners first reported a position in CARM in Q2 2021 and held it in 7 quarters. The position peaked at $186K in Q2 2021. 37 funds tracked by Wall St. Rank hold CARM as of Q1 2023.

  • Venture Visionary Partners reported no remaining Carisma Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Venture Visionary Partners sold 1,500 Carisma Therapeutics shares in Q1 2023, an estimated $18.3K.
  • Venture Visionary Partners first reported a position in Carisma Therapeutics in Q2 2021 and held it in 7 quarters.
  • Venture Visionary Partners's Carisma Therapeutics position peaked at $186K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q1 2023.

Based on Venture Visionary Partners's 13F filing for Q1 2023, filed 13 Apr 2023.